{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:37:49Z","timestamp":1793090269633,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105574","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:44:30Z","timestamp":1788417870000},"page":"105574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diffuse intrinsic pontine glioma in the era of H3 K27-altered diffuse midline glioma"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-9489","authenticated-orcid":false,"given":"Shepeng","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3442-2015","authenticated-orcid":false,"given":"Zhenjiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2018.12.043","article-title":"A phase 1\/2 trial of reirradiation for diffuse intrinsic pontine glioma","volume":"104","author":"Amsbaugh","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105574_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.23.01134","article-title":"ONC201 (dordaviprone) in recurrent H3 K27M-mutant diffuse midline glioma","volume":"42","author":"Arrillaga-Romany","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-020-02194-y","article-title":"Infratentorial IDH-mutant astrocytoma is a distinct subtype","volume":"140","author":"Banan","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"8056","key":"10.1016\/j.critrevonc.2026.105574_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41586-024-08579-3","article-title":"GABAergic neuron-to-glioma synapses in diffuse midline gliomas","volume":"639","author":"Barron","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00401-014-1337-4","article-title":"Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas","volume":"128","author":"Bechet","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/cncr.21749","article-title":"Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma","volume":"106","author":"Broniscer","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105574_bib8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/neuonc\/noac030","article-title":"Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma","volume":"24","author":"Cantor","year":"2022","journal-title":"Neuro Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00401-020-02142-w","article-title":"Histone H3 wild-type DIPG\/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation","volume":"139","author":"Castel","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\\'s Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105574_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100851","article-title":"Interdisciplinary care of children with diffuse midline glioma","volume":"35","author":"Coleman","year":"2023","journal-title":"Neoplasia"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105574_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105574_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115165","article-title":"Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: results of an international academia-driven compassionate use program","volume":"216","author":"Di Carlo","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41591-020-0827-2","article-title":"Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma","volume":"26","author":"Donovan","year":"2020","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105574_bib16","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/neuonc\/noad031","article-title":"Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908","volume":"25","author":"Dunkel","year":"2023","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib17","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1038\/s41598-021-85180-y","article-title":"Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model","volume":"11","author":"Englander","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/neuonc\/noab140","article-title":"Characteristics of patients \u226510 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG\/DMG Registry","volume":"24","author":"Erker","year":"2022","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib19","article-title":"Does a bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review","volume":"4","author":"Evans","year":"2022","journal-title":"Neurooncol Adv."},{"issue":"6386","key":"10.1016\/j.critrevonc.2026.105574_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat. Genet."},{"issue":"26","key":"10.1016\/j.critrevonc.2026.105574_bib22","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma","volume":"386","author":"G\u00e1llego P\u00e9rez-Larraya","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnen\/nlad103","article-title":"H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications","volume":"83","author":"Gestrich","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105574_bib24","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00381-020-04589-4","article-title":"Retrospective analysis of the clinical and radiological features of 94 consecutive DIPGs patients to investigate the factors determining the development of hydrocephalus and its impact on clinical status and survival","volume":"36","author":"Giussani","year":"2020","journal-title":"Childs Nerv. Syst."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105574_bib25","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41591-023-02555-6","article-title":"A H3K27M-targeted vaccine in adults with diffuse midline glioma","volume":"29","author":"Grassl","year":"2023","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1021\/acschembio.9b00222","article-title":"Mitochondrial protease ClpP is a target for the anticancer compounds ONC201 and related analogues","volume":"14","author":"Graves","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.critrevonc.2026.105574_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.wneu.2018.12.096","article-title":"Safety and efficacy of endoscopic third ventriculostomy in diffuse intrinsic pontine glioma related hydrocephalus: a systematic review","volume":"124","author":"Guida","year":"2019","journal-title":"World Neurosurg."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105574_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/neuonc\/noy070","article-title":"Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"20","author":"Gupta","year":"2018","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-005-9029-5","article-title":"Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma","volume":"77","author":"Gururangan","year":"2006","journal-title":"J. Neurooncol"},{"issue":"35","key":"10.1016\/j.critrevonc.2026.105574_bib31","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1200\/JCO.24.00709","article-title":"Comments and controversies in oncology: the tribulations of trials developing ONC201","volume":"42","author":"Hansford","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11060-017-2546-1","article-title":"Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis","volume":"135","author":"Hassan","year":"2017","journal-title":"J. Neurooncol"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib34","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/neuonc\/noaa278","article-title":"Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery","volume":"23","author":"Haydar","year":"2021","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105574_bib35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/neuonc\/nor076","article-title":"Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging","volume":"13","author":"Hipp","year":"2011","journal-title":"Neuro Oncol."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105574_bib36","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1078-0432.CCR-20-2291","article-title":"Concurrent dexamethasone limits the clinical benefit of immune checkpoint blockade in glioblastoma","volume":"27","author":"Iorgulescu","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","article-title":"Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality","volume":"35","author":"Ishizawa","year":"2019","journal-title":"Cancer Cell."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3171\/2022.12.JNS221954","article-title":"2-Hydroxyglutarate magnetic resonance spectroscopy in adult brainstem glioma","volume":"139","author":"Iwahashi","year":"2023","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-013-1189-0","article-title":"Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma","volume":"114","author":"Jackson","year":"2013","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nou104","article-title":"Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria","volume":"17","author":"Jansen","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105574_bib42","series-title":"Inc. MODEYSO (dordaviprone) capsules, for oral use: U.S. prescribing information","author":"Jazz Pharmaceuticals","year":"2025"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105574_bib43","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41588-022-01205-w","article-title":"K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas","volume":"54","author":"Jessa","year":"2022","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105574_bib44","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/neuonc\/noag117","article-title":"Point\/counterpoint: dordaviprone for diffuse midline glioma\u2014a landmark approval or a premature step?","volume":"28","author":"Khasraw","year":"2026","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib47","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1093\/neuonc\/noae064.035","article-title":"CNSC-02. Pediatric brain tumor consortium (PBTC)-056: a phase 1 study of the ADAM-10 inhibitor, INCB007839, in children with recurrent\/progressive high-grade gliomas to target microenvironmental neuroligin-3.","volume":"26","author":"Lenzen","year":"2024","journal-title":"Neuro Oncol"},{"issue":"6134","key":"10.1016\/j.critrevonc.2026.105574_bib48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib49","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1038\/s41598-021-84513-1","article-title":"Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105574_bib50","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.23.02019","article-title":"Phase I trial of GD2.CART cells augmented with constitutive interleukin-7 receptor for treatment of high-grade pediatric CNS tumors","volume":"42","author":"Lin","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib51","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ijrobp.2008.12.032","article-title":"Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas","volume":"75","author":"Liu","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105574_bib52","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41588-022-01236-3","article-title":"The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location","volume":"54","author":"Liu","year":"2022","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105574_bib53","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ccell.2024.08.006","article-title":"GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105574_bib54","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib55","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib56","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41591-023-02276-w","article-title":"Tumor inflammation-associated neurotoxicity","volume":"29","author":"Mahdi","year":"2023","journal-title":"Nat. Med."},{"issue":"7903","key":"10.1016\/j.critrevonc.2026.105574_bib57","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-020-03416-9","article-title":"Provider views on perioperative steroid use for patients with newly diagnosed pediatric brain tumors","volume":"147","author":"Malbari","year":"2020","journal-title":"J. Neurooncol"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib59","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","article-title":"There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy","volume":"43","author":"Mandell","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib60","article-title":"MRI-guided focused ultrasound blood-brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model","volume":"5","author":"Martinez","year":"2023","journal-title":"Neurooncol Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaoncol.2022.5843","article-title":"Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial","volume":"9","author":"Mascia","year":"2023","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib62","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/cancers17060931","article-title":"Updates in diagnostic techniques and experimental therapies for diffuse intrinsic pontine glioma","volume":"17","author":"McVeigh","year":"2025","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105574_bib63","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/neuonc\/noac035","article-title":"Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients","volume":"24","author":"Miller","year":"2022","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib64","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat. Med."},{"issue":"8046","key":"10.1016\/j.critrevonc.2026.105574_bib65","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib66","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1158\/1078-0432.CCR-20-0894","article-title":"Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice","volume":"27","author":"Montay-Gruel","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105574_bib68","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1172\/JCI140378","article-title":"Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma","volume":"130","author":"Mueller","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00381-019-04420-9","article-title":"Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma","volume":"36","author":"Muroi","year":"2020","journal-title":"Childs Nerv. Syst."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib70","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3174\/ajnr.A9126","article-title":"Focused ultrasound in brain tumors: mechanisms, imaging guidance, and emerging clinical applications","volume":"47","author":"Nabavizadeh","year":"2026","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.critrevonc.2026.105574_bib71","series-title":"NCCN Clinical Practice Guidelines in Oncology: Pediatric Central Nervous System Cancers. Version 2.2025.","author":"National Comprehensive Cancer Network","year":"2025"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/1545-5017.70042","article-title":"Hydrocephalus in patients with diffuse intrinsic pontine glioma: a systematic review of the literature","volume":"73","author":"Nigro","year":"2026","journal-title":"Pediatric Blood Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00701-024-06154-3","article-title":"Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults","volume":"166","author":"Oki","year":"2024","journal-title":"Acta Neurochir."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib74","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ijrobp.2024.01.219","article-title":"Immune response following FLASH and conventional radiation in diffuse midline glioma","volume":"119","author":"Padilla","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105574_bib75","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","article-title":"Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy","volume":"24","author":"Panditharatna","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105574_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100876","article-title":"Past, present and future of focused ultrasound as an adjunct or complement to DIPG\/DMG therapy: a consensus of the 2021 FUSF DIPG meeting","volume":"37","author":"Parekh","year":"2023","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib77","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/neuonc\/noaa295","article-title":"Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017","volume":"23","author":"Patil","year":"2021","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00401-025-02945-9","article-title":"Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM","volume":"150","author":"Pfaff","year":"2025","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105574_bib79","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/neuonc\/noac041","article-title":"Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas","volume":"24","author":"Przystal","year":"2022","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105574_bib81","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00381-015-2832-1","article-title":"Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas","volume":"31","author":"Puget","year":"2015","journal-title":"Childs Nerv. Syst."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105574_bib82","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00401-023-02640-7","article-title":"Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations","volume":"146","author":"Roberts","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib83","article-title":"ID #174 Pioneering quad-targeting CAR T cell therapy in pediatric CNS tumors-analysis from the completed first-in-human phase 1 trial BrainChild-04","volume":"2","author":"Ronsley","year":"2026","journal-title":"Neuro-Oncol. Pediatrics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib84","first-page":"105","article-title":"Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03","volume":"13","author":"Ronsley","year":"2026","journal-title":"Neurooncol. Pract."},{"issue":"7384","key":"10.1016\/j.critrevonc.2026.105574_bib85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib86","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-010-0301-y","article-title":"Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma","volume":"102","author":"Sethi","year":"2011","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.critrevonc.2026.105574_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110865","article-title":"Re-irradiation for children with diffuse intrinsic pontine glioma and diffuse midline glioma","volume":"207","author":"Shariff","year":"2025","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/neuonc\/noaa251","article-title":"A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR","volume":"23","author":"Sievers","year":"2021","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib89","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3171\/2024.8.JNS241180","article-title":"A comprehensive multicenter analysis of clinical, molecular, and imaging characteristics and outcomes of H3 K27-altered diffuse midline glioma in adults","volume":"142","author":"Sim","year":"2025","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00381-006-0168-6","article-title":"Leptomeninges as a site of relapse in locally controlled, diffuse pontine glioma with review of literature","volume":"23","author":"Singh","year":"2007","journal-title":"Childs Nerv. Syst."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105574_bib91","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/neuonc\/noaf039","article-title":"Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-omburtamab for diffuse intrinsic pontine glioma","volume":"27","author":"Souweidane","year":"2025","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib92","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-011-0601-x","article-title":"Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma","volume":"105","author":"Steffen-Smith","year":"2011","journal-title":"J. Neurooncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-023-04269-8","article-title":"First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1\/2 study using low-intensity focused ultrasound","volume":"162","author":"Syed","year":"2023","journal-title":"J. Neurooncol"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105574_bib94","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat. Genet."},{"issue":"7986","key":"10.1016\/j.critrevonc.2026.105574_bib95","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib96","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ijrobp.2019.11.020","article-title":"Defining optimal target volumes of conformal radiation therapy for diffuse intrinsic pontine glioma","volume":"106","author":"Tinkle","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105574_bib97","series-title":"FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma","author":"U.S. Food and Drug Administration","year":"2025"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib98","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-016-2363-y","article-title":"Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease","volume":"132","author":"Veldhuijzen van Zanten","year":"2017","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib99","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-017-2514-9","article-title":"External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry","volume":"134","author":"Veldhuijzen van Zanten","year":"2017","journal-title":"J. Neurooncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"issue":"7775","key":"10.1016\/j.critrevonc.2026.105574_bib101","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105574_bib102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","article-title":"Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety","volume":"13","author":"Vitanza","year":"2023","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib103","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib104","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11060-021-03890-9","article-title":"H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients","volume":"155","author":"Vuong","year":"2021","journal-title":"J. Neurooncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105574_bib105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/neuonc\/nos330","article-title":"A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method","volume":"15","author":"Walker","year":"2013","journal-title":"Neuro Oncol."},{"issue":"824","key":"10.1016\/j.critrevonc.2026.105574_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq6645","article-title":"Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma","volume":"17","author":"Wu","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105574_bib107","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib108","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2022.01.054","article-title":"Hypofractionated radiation therapy for diffuse intrinsic pontine glioma: a noninferiority randomized study including 253 children","volume":"113","author":"Zaghloul","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105574_bib109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J. Neurooncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:07:24Z","timestamp":1793088444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":109,"alternative-id":["S1040842826004610"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105574","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffuse intrinsic pontine glioma in the era of H3 K27-altered diffuse midline glioma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105574"}}